Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 17, 2004

View Archived Issues

Efficacy of stampidine shown in vitro against resistant HIV-1 isolates

Antiinflammatory action of ethyl pyruvate mediated in part via GSH depletion

Good safety profile reported for BBR-3576 in patients with advanced solid tumors

Full clinical results reported for eculizumab in paroxysmal nocturnal hemoglobinuria

2003 record year at Serono

New Viracept formulation recommended for approval in Europe

Iseganan program selected for CMA Pilot 2 program

Medtronic receives conditional approval to commence ENDEAVOR III trial

University of Pennsylvania studies chromium picolinate for metabolic syndrome

Vivus to develop Testosterone MDTS, Estradiol MDTS for U.S.

Salix updates Q4 and year-end 2003 developments

Seattle Genetics highlights 2003 development progress

Two series of factor VIIa inhibitors presented by BMS researchers

Novel renin inhibitors in early development at Actelion

Spanish researchers describe new muscarinic M3 antagonists and their use

Novel oxytocin antagonists and their use as tocolytics reported by ARS team

Indian scientists claim new anthramycin-based antitumor agents

Allergan patent covers antitumor agents for breast and prostate cancer therapy

New COX inhibitors identified by Boehringer Ingelheim scientists

Two novel series of antibacterial agents prepared and tested at GSK

Elan completes recovery plan

Erbitux receives FDA approval

Aventis selects target in GPC Biotech osteoarthritis alliance

FDA approval for benazepril hydrochloride

Prevnar allocation program continues

Concerta approved in Australia

Symbollon plans pivotal IoGen trial for fibrocystic breast disease

Altana seeks European approval for Daxas

Dermatrends demonstrates effective transdermal delivery of testosterone

Neurologix completes merger with Change Technology Partners

E-5564 reported safe and effective in a human model of clinical sepsis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...